6.45
price up icon0.78%   0.05
after-market Handel nachbörslich: 6.39 -0.06 -0.93%
loading

CorMedix Inc Aktie (CRMD) Neueste Nachrichten

pulisher
Mar 11, 2026

CorMedix at Citizens Life Sciences: Strategic Expansion and Growth By Investing.com - Investing.com Canada

Mar 11, 2026
pulisher
Mar 10, 2026

Cormedix Earnings Call: Peak DEFENCATH, Tough Road Ahead - TipRanks

Mar 10, 2026
pulisher
Mar 10, 2026

CorMedix at Leerink Conference: Strategic Evolution and Market Potential - Investing.com

Mar 10, 2026
pulisher
Mar 10, 2026

CorMedix reports Q4 revenue of $128.6M, reaffirms 2026 guidance - Investing.com Nigeria

Mar 10, 2026
pulisher
Mar 09, 2026

What is CorMedix Inc.’s book value per shareMarket Weekly Review & Fast Moving Stock Trade Plans - baoquankhu1.vn

Mar 09, 2026
pulisher
Mar 08, 2026

CorMedix (CRMD) Is Down 9.4% After Reaffirming 2026 Guidance and Reporting Profit SwingWhat's Changed - simplywall.st

Mar 08, 2026
pulisher
Mar 07, 2026

CorMedix outlines $300M–$320M revenue and $100M–$125M EBITDA targets for 2026 amid DefenCath transition and Melinta integration - MSN

Mar 07, 2026
pulisher
Mar 07, 2026

CorMedix Therapeutics 2026: Portfolio Expansion, Financial Highlights, DefenCath Launch & Growth Pipeline in Specialty Pharma 1234567 - Minichart

Mar 07, 2026
pulisher
Mar 07, 2026

CorMedix Strikes $300M Deal For Melinta Therapeutics, Retail Calls It A ‘Wonderful Acquisition’ - MSN

Mar 07, 2026
pulisher
Mar 06, 2026

Leerink cuts CorMedix stock price target on expense adjustments - Investing.com India

Mar 06, 2026
pulisher
Mar 06, 2026

Update Recap: What is the target price for CorMedix Inc stockWeekly Risk Report & Real-Time Market Sentiment Reports - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

CorMedix 2025 Financial Results: $163.1M Profit, $311.7M RevenueNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform

Mar 06, 2026
pulisher
Mar 06, 2026

CorMedix Reaffirms DefenCath 2027 Sales and Outlook - TipRanks

Mar 06, 2026
pulisher
Mar 06, 2026

Assessing CorMedix (CRMD) Valuation After Recent Share Price Weakness And Growth Expectations - Yahoo Finance

Mar 06, 2026
pulisher
Mar 06, 2026

CorMedix Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 06, 2026
pulisher
Mar 06, 2026

CorMedix Inc. (NASDAQ:CRMD) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 06, 2026
pulisher
Mar 06, 2026

CorMedix Buyback And REZZAYO Data Shape Valuation And Risk Profile - Yahoo Finance

Mar 06, 2026
pulisher
Mar 06, 2026

CorMedix reports Q4 revenue of $128.6M, reaffirms 2026 guidance By Investing.com - Investing.com Canada

Mar 06, 2026
pulisher
Mar 06, 2026

CorMedix Q4 Revenue Improves; Reaffirms FY26 Outlook; Plans To Report Phase III REZZAYO Data In Q2 - Nasdaq

Mar 06, 2026
pulisher
Mar 05, 2026

CorMedix nears an 11-month low after earnings miss - MSN

Mar 05, 2026
pulisher
Mar 05, 2026

Truist reiterates CorMedix stock rating on steady guidance - Investing.com India

Mar 05, 2026
pulisher
Mar 05, 2026

Truist reiterates CorMedix stock rating on steady guidance By Investing.com - Investing.com South Africa

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix (CRMD) Q4 2025 Earnings Call Transcript - AOL.com

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix (CRMD) Valuation Check After Recent Share Price Swings And Melinta Acquisition Narrative - simplywall.st

Mar 05, 2026
pulisher
Mar 05, 2026

Why Did CRMD Stock Tumble Over 11% Today? - Stocktwits

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix Shares Fall After Q4 Profit Miss - marketscreener.com

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix stock drops after earnings: is this dip a buy before key catalyst? - TradingView

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix: Fourth Quarter Financial Results Overview - Bitget

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix stock falls after earnings miss (CRMD:NASDAQ) - Seeking Alpha

Mar 05, 2026
pulisher
Mar 05, 2026

Earnings call transcript: CorMedix Q4 2025 results miss EPS, stock dips - Investing.com Nigeria

Mar 05, 2026
pulisher
Mar 05, 2026

Cormedix Stock Pre-Market (+6.2%) : Technical Move Ahead of Key Q2 Catalyst - Trefis

Mar 05, 2026
pulisher
Mar 05, 2026

Earnings call transcript: CorMedix Q4 2025 results miss EPS, stock dips By Investing.com - Investing.com South Africa

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix (CRMD) reports higher Q4 2025 profit on strong revenue growth - AlphaStreet

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix (CRMD) Lags Q4 Earnings Estimates - Yahoo Finance

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix Q4 2025 Earnings Call Transcript - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Cormedix Earnings Review: Q4 Summary - Benzinga

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix: Q4 Earnings Snapshot - kare11.com

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix earnings missed by $0.69, revenue topped estimates - Investing.com

Mar 05, 2026
pulisher
Mar 05, 2026

CORMEDIX ($CRMD) Releases Q4 2025 Earnings - Quiver Quantitative

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix stock falls 5% on fourth quarter earnings miss By Investing.com - Investing.com Australia

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix stock falls 5% on fourth quarter earnings miss - Investing.com India

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results - TradingView

Mar 05, 2026
pulisher
Mar 05, 2026

CorMedix Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - The Manila Times

Mar 05, 2026
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):